Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)

Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Behavioural brain research 2024-01, Vol.456, p.114708-114708, Article 114708
Hauptverfasser: Nawata, Yoko, Ooishi, Rina, Nishioku, Tsuyoshi, Yamaguchi, Taku
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 114708
container_issue
container_start_page 114708
container_title Behavioural brain research
container_volume 456
creator Nawata, Yoko
Ooishi, Rina
Nishioku, Tsuyoshi
Yamaguchi, Taku
description Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence using a methamphetamine (METH) self-administration rat model. Rats were trained to press a lever for 0.02-mg intravenous METH infusions paired with drug-associated cues (light and tone) under a fixed ratio 1 schedule. After a 10-day METH self-administration acquisition phase, rats underwent extinction training. A reinstatement test was conducted after fulfilment of the extinction criterion under saline infusions. Re-exposure to METH-associated cues or a priming injection of METH (1.0 mg/kg, i.p.) significantly reinstated METH-seeking behaviors. Pretreatment with nalmefene (10 mg/kg, i.p.) immediately before reinstatement tests significantly attenuated the METH-seeking behaviors induced by both cues and METH priming injection. To investigate the mechanism of effect of nalmefene, we also tested the ability of a group II metabotropic glutamate receptors (mGluR2/3) antagonist, LY341495, to the ameliorating effects of nalmefene. Pretreatment with LY341495 (1.0 mg/kg, i.p.) before nalmefene administration antagonized the effect of nalmefene on reinstatement. LY341495 alone did not affect the reinstatement of lever pressing. We found that nalmefene attenuates METH-seeking behaviors during withdrawal, and this attenuation of reinstatement is mediated by the activation of mGluR2/3. The present findings suggest that nalmefene could decrease incentive motivation for drug use in psychostimulant dependence. •We examined the potential of nalmefene for treating psychostimulant dependence.•Nalmefene attenuates methamphetamine-seeking behaviors in rats.•mGluR2/3 antagonist reverses the attenuating effect of nalmefene on reinstatement.•Nalmefene may be useful for an anti-craving agent in psychostimulant dependence.
doi_str_mv 10.1016/j.bbr.2023.114708
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2876636274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432823004266</els_id><sourcerecordid>2876636274</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-d14ccc5bec11e28bba9d8f6704d3da3199f914d724811bcef95a03b9e3aeadf63</originalsourceid><addsrcrecordid>eNp9kM1OGzEUhS1UJFLgAdh5SReT-C_zI1YoaiFS1EoI1pbtuZNxmLEH2xOJZ-hL4yhdd3Xu4nzn6hyE7ihZUkLL1WGpdVgywviSUlGR-gItaF2xolqL5htaZE9ZCM7qK_Q9xgMhRJA1XaC_v9UwQgcOsEoJ3KwSRBzAupjyOYJL2Hd4hNSrceohqdE6KCLAu3V7rKFXR-sDtg4HlSJOffDzvsf7LBPebk-k0j4FP1mD98OcA3Ju_mBgSj5EfD8-DfMLW_EfN-iyU0OE2396jd5-_XzdPBe7P0_bzeOuMKxmqWipMMasNRhKgdVaq6atu7IiouWt4rRpuoaKtmKiplQb6Jq1Ilw3wBWotiv5Nbo_507Bf8wQkxxtNDAMyoGfo2R1VZa8ZJXIVnq2muBjDNDJKdhRhU9JiTwNLw8yDy9Pw8vz8Jl5ODOQOxwtBBmNBWegtbl1kq23_6G_AGLGjyk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2876636274</pqid></control><display><type>article</type><title>Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)</title><source>Access via ScienceDirect (Elsevier)</source><creator>Nawata, Yoko ; Ooishi, Rina ; Nishioku, Tsuyoshi ; Yamaguchi, Taku</creator><creatorcontrib>Nawata, Yoko ; Ooishi, Rina ; Nishioku, Tsuyoshi ; Yamaguchi, Taku</creatorcontrib><description>Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence using a methamphetamine (METH) self-administration rat model. Rats were trained to press a lever for 0.02-mg intravenous METH infusions paired with drug-associated cues (light and tone) under a fixed ratio 1 schedule. After a 10-day METH self-administration acquisition phase, rats underwent extinction training. A reinstatement test was conducted after fulfilment of the extinction criterion under saline infusions. Re-exposure to METH-associated cues or a priming injection of METH (1.0 mg/kg, i.p.) significantly reinstated METH-seeking behaviors. Pretreatment with nalmefene (10 mg/kg, i.p.) immediately before reinstatement tests significantly attenuated the METH-seeking behaviors induced by both cues and METH priming injection. To investigate the mechanism of effect of nalmefene, we also tested the ability of a group II metabotropic glutamate receptors (mGluR2/3) antagonist, LY341495, to the ameliorating effects of nalmefene. Pretreatment with LY341495 (1.0 mg/kg, i.p.) before nalmefene administration antagonized the effect of nalmefene on reinstatement. LY341495 alone did not affect the reinstatement of lever pressing. We found that nalmefene attenuates METH-seeking behaviors during withdrawal, and this attenuation of reinstatement is mediated by the activation of mGluR2/3. The present findings suggest that nalmefene could decrease incentive motivation for drug use in psychostimulant dependence. •We examined the potential of nalmefene for treating psychostimulant dependence.•Nalmefene attenuates methamphetamine-seeking behaviors in rats.•mGluR2/3 antagonist reverses the attenuating effect of nalmefene on reinstatement.•Nalmefene may be useful for an anti-craving agent in psychostimulant dependence.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2023.114708</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Drug-seeking behavior ; Methamphetamine ; mGluR2/3 ; Nalmefene ; Self-administration</subject><ispartof>Behavioural brain research, 2024-01, Vol.456, p.114708-114708, Article 114708</ispartof><rights>2023 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c282t-d14ccc5bec11e28bba9d8f6704d3da3199f914d724811bcef95a03b9e3aeadf63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbr.2023.114708$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Nawata, Yoko</creatorcontrib><creatorcontrib>Ooishi, Rina</creatorcontrib><creatorcontrib>Nishioku, Tsuyoshi</creatorcontrib><creatorcontrib>Yamaguchi, Taku</creatorcontrib><title>Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)</title><title>Behavioural brain research</title><description>Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence using a methamphetamine (METH) self-administration rat model. Rats were trained to press a lever for 0.02-mg intravenous METH infusions paired with drug-associated cues (light and tone) under a fixed ratio 1 schedule. After a 10-day METH self-administration acquisition phase, rats underwent extinction training. A reinstatement test was conducted after fulfilment of the extinction criterion under saline infusions. Re-exposure to METH-associated cues or a priming injection of METH (1.0 mg/kg, i.p.) significantly reinstated METH-seeking behaviors. Pretreatment with nalmefene (10 mg/kg, i.p.) immediately before reinstatement tests significantly attenuated the METH-seeking behaviors induced by both cues and METH priming injection. To investigate the mechanism of effect of nalmefene, we also tested the ability of a group II metabotropic glutamate receptors (mGluR2/3) antagonist, LY341495, to the ameliorating effects of nalmefene. Pretreatment with LY341495 (1.0 mg/kg, i.p.) before nalmefene administration antagonized the effect of nalmefene on reinstatement. LY341495 alone did not affect the reinstatement of lever pressing. We found that nalmefene attenuates METH-seeking behaviors during withdrawal, and this attenuation of reinstatement is mediated by the activation of mGluR2/3. The present findings suggest that nalmefene could decrease incentive motivation for drug use in psychostimulant dependence. •We examined the potential of nalmefene for treating psychostimulant dependence.•Nalmefene attenuates methamphetamine-seeking behaviors in rats.•mGluR2/3 antagonist reverses the attenuating effect of nalmefene on reinstatement.•Nalmefene may be useful for an anti-craving agent in psychostimulant dependence.</description><subject>Drug-seeking behavior</subject><subject>Methamphetamine</subject><subject>mGluR2/3</subject><subject>Nalmefene</subject><subject>Self-administration</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OGzEUhS1UJFLgAdh5SReT-C_zI1YoaiFS1EoI1pbtuZNxmLEH2xOJZ-hL4yhdd3Xu4nzn6hyE7ihZUkLL1WGpdVgywviSUlGR-gItaF2xolqL5htaZE9ZCM7qK_Q9xgMhRJA1XaC_v9UwQgcOsEoJ3KwSRBzAupjyOYJL2Hd4hNSrceohqdE6KCLAu3V7rKFXR-sDtg4HlSJOffDzvsf7LBPebk-k0j4FP1mD98OcA3Ju_mBgSj5EfD8-DfMLW_EfN-iyU0OE2396jd5-_XzdPBe7P0_bzeOuMKxmqWipMMasNRhKgdVaq6atu7IiouWt4rRpuoaKtmKiplQb6Jq1Ilw3wBWotiv5Nbo_507Bf8wQkxxtNDAMyoGfo2R1VZa8ZJXIVnq2muBjDNDJKdhRhU9JiTwNLw8yDy9Pw8vz8Jl5ODOQOxwtBBmNBWegtbl1kq23_6G_AGLGjyk</recordid><startdate>20240105</startdate><enddate>20240105</enddate><creator>Nawata, Yoko</creator><creator>Ooishi, Rina</creator><creator>Nishioku, Tsuyoshi</creator><creator>Yamaguchi, Taku</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240105</creationdate><title>Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)</title><author>Nawata, Yoko ; Ooishi, Rina ; Nishioku, Tsuyoshi ; Yamaguchi, Taku</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-d14ccc5bec11e28bba9d8f6704d3da3199f914d724811bcef95a03b9e3aeadf63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Drug-seeking behavior</topic><topic>Methamphetamine</topic><topic>mGluR2/3</topic><topic>Nalmefene</topic><topic>Self-administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nawata, Yoko</creatorcontrib><creatorcontrib>Ooishi, Rina</creatorcontrib><creatorcontrib>Nishioku, Tsuyoshi</creatorcontrib><creatorcontrib>Yamaguchi, Taku</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nawata, Yoko</au><au>Ooishi, Rina</au><au>Nishioku, Tsuyoshi</au><au>Yamaguchi, Taku</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)</atitle><jtitle>Behavioural brain research</jtitle><date>2024-01-05</date><risdate>2024</risdate><volume>456</volume><spage>114708</spage><epage>114708</epage><pages>114708-114708</pages><artnum>114708</artnum><issn>0166-4328</issn><eissn>1872-7549</eissn><abstract>Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence using a methamphetamine (METH) self-administration rat model. Rats were trained to press a lever for 0.02-mg intravenous METH infusions paired with drug-associated cues (light and tone) under a fixed ratio 1 schedule. After a 10-day METH self-administration acquisition phase, rats underwent extinction training. A reinstatement test was conducted after fulfilment of the extinction criterion under saline infusions. Re-exposure to METH-associated cues or a priming injection of METH (1.0 mg/kg, i.p.) significantly reinstated METH-seeking behaviors. Pretreatment with nalmefene (10 mg/kg, i.p.) immediately before reinstatement tests significantly attenuated the METH-seeking behaviors induced by both cues and METH priming injection. To investigate the mechanism of effect of nalmefene, we also tested the ability of a group II metabotropic glutamate receptors (mGluR2/3) antagonist, LY341495, to the ameliorating effects of nalmefene. Pretreatment with LY341495 (1.0 mg/kg, i.p.) before nalmefene administration antagonized the effect of nalmefene on reinstatement. LY341495 alone did not affect the reinstatement of lever pressing. We found that nalmefene attenuates METH-seeking behaviors during withdrawal, and this attenuation of reinstatement is mediated by the activation of mGluR2/3. The present findings suggest that nalmefene could decrease incentive motivation for drug use in psychostimulant dependence. •We examined the potential of nalmefene for treating psychostimulant dependence.•Nalmefene attenuates methamphetamine-seeking behaviors in rats.•mGluR2/3 antagonist reverses the attenuating effect of nalmefene on reinstatement.•Nalmefene may be useful for an anti-craving agent in psychostimulant dependence.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.bbr.2023.114708</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0166-4328
ispartof Behavioural brain research, 2024-01, Vol.456, p.114708-114708, Article 114708
issn 0166-4328
1872-7549
language eng
recordid cdi_proquest_miscellaneous_2876636274
source Access via ScienceDirect (Elsevier)
subjects Drug-seeking behavior
Methamphetamine
mGluR2/3
Nalmefene
Self-administration
title Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A17%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nalmefene%20attenuates%20reinstatement%20of%20methamphetamine-seeking%20behavior%20in%20rats%20through%20group%20II%20metabotropic%20glutamate%20receptors%20(mGluR2/3)&rft.jtitle=Behavioural%20brain%20research&rft.au=Nawata,%20Yoko&rft.date=2024-01-05&rft.volume=456&rft.spage=114708&rft.epage=114708&rft.pages=114708-114708&rft.artnum=114708&rft.issn=0166-4328&rft.eissn=1872-7549&rft_id=info:doi/10.1016/j.bbr.2023.114708&rft_dat=%3Cproquest_cross%3E2876636274%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2876636274&rft_id=info:pmid/&rft_els_id=S0166432823004266&rfr_iscdi=true